This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Founded in 1968 and headquartered in Cincinnati, OH, Cintas Corporation provides specialized services to businesses of all types throughout North America. It also operates in Europe, Asia and Latin America. The company designs, manufactures, implements corporate identity uniform programs, and provides entrance mats, restroom supplies, promotional products and first aid and safety products for diversified businesses. Notably, the company provides products and services through distribution and retail channels to small service and manufacturing companies as well as leading corporations.
Has Belden (BDC) Outpaced Other Industrial Products Stocks This Year?
by Zacks Equity Research
Here is how Belden (BDC) and Cintas (CTAS) have performed compared to their sector so far this year.
Cintas (CTAS) Stock Gains 14% in 3 Months: What's Driving It?
by Zacks Equity Research
Cintas (CTAS) benefits from strengthening end-market businesses, focus on product development and technological advancement, cost control and shareholder-friendly policies.
Stanley Black (SWK) Makes Accounting Changes, Updates View
by Zacks Equity Research
Stanley Black (SWK) updates its third-quarter reported earnings and projections for 2021, following amendments to its accounting policy.
Roper (ROP) Board Approves 10% Hike in Quarterly Dividend Rate
by Zacks Equity Research
Roper's (ROP) board hikes the quarterly dividend rate by 10%. The move is in sync with the company's shareholder-friendly policies.
Is Invesco S&P 500 Equal Weight Industrials ETF (RGI) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RGI
Cintas (CTAS) Up 11.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cintas (CTAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here is Why Growth Investors Should Buy Cintas (CTAS) Now
by Zacks Equity Research
Cintas (CTAS) possesses solid growth attributes, which could help it handily outperform the market.
Should You Invest in the Invesco S&P 500 Equal Weight Industrials ETF (RGI)?
by Zacks Equity Research
Sector ETF report for RGI
Here's Why it is Worth Investing in Cintas (CTAS) Stock Now
by Zacks Equity Research
Cintas (CTAS) stands to benefit from strength across its end markets, growth investments, focus on operational execution, and shareholder-friendly policies.
Cintas (CTAS) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Cintas (CTAS) could produce exceptional returns because of its solid growth attributes.
Company News for Sep 30, 2021
by Zacks Equity Research
Companies in the news are: CTAS, NCNA, GOVX, LCID
Cintas' (CTAS) Q1 Earnings and Sales Beat, Increase Y/Y
by Zacks Equity Research
Cintas' (CTAS) fiscal Q1 results reflect strength in Uniform Rental and Facility Services, offset by high costs & expenses. Earnings and sales projections for fiscal 2022 imply year-over-year growth.
Cintas (CTAS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 12.68% and 1.51%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?
Cintas (CTAS) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Cintas (CTAS) Q1 earnings to reflect healthy business in the hygiene and healthcare markets, gains from buyouts, and solid product offerings. High costs and taxes are likely to have been concerning.
Micron, Cintas, McCormick and JPMorgan are part of Zacks Earnings Preview
by Zacks Equity Research
Micron, Cintas, McCormick and JPMorgan are part of Zacks Earnings Preview
Making Sense of the Q3 Earnings Picture and Beyond
by Sheraz Mian
Recent updates on the revisions trends have been somewhat disconcerting, as you can see in the chart below that tracks the evolution of Q3 earnings growth expectations...
Earnings Preview: Cintas (CTAS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Cintas (CTAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cintas (CTAS) Tops on Q4 Earnings & Sales, Gives Solid View
by Zacks Equity Research
Cintas' (CTAS) Q4 results reflect gains from strength in Uniform Rental and Facility Services, offset by higher costs and expenses. Earnings and revenue projections for fiscal 2022 suggest year-over-year growth.
Cintas (CTAS) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 6.01% and 0.63%, respectively, for the quarter ended May 2021. Do the numbers hold clues to what lies ahead for the stock?
5 Earnings Charts to Kick off Earnings Season
by Tracey Ryniec
Investors should be watching more than just the big banks this week.
Cintas (CTAS) to Report Q4 Earnings Results: What's in Store?
by Zacks Equity Research
Cintas (CTAS) Q4 earnings to reflect strength in healthcare and hygiene markets, and healthy supply chain and distribution network. Coronavirus woes in some markets are likely to have been concerning.
Cintas (CTAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Cintas (CTAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cintas (CTAS) Exhibits Solid Prospects, Challenges Persist
by Zacks Equity Research
Cintas (CTAS) is likely to benefit from strength across its healthcare and hygiene end markets, acquired asset and shareholder-friendly policies. Soft end markets and high-debt are concerning.
Cintas (CTAS) Up 2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cintas (CTAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Cintas (CTAS) Stock Might be a Great Pick
by Zacks Equity Research
Cintas (CTAS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.